BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33527034)

  • 1. Transcriptional E2F1/2/3/6 as potential prognostic biomarkers in cutaneous melanoma.
    Li J; Shu XL; Shao Q; Luo Q; Diao QC; Zhang X; Sui JD; Guo J; Tao D; Zhou X; Wang Y; Wang C
    Am J Transl Res; 2021; 13(1):420-433. PubMed ID: 33527034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Potential Therapeutic Target for E2F1 and Prognostic Factors of E2F1/2/3/5/7/8 in Human Gastric Cancer.
    Liu X; Hu C
    Mol Ther Methods Clin Dev; 2020 Sep; 18():824-838. PubMed ID: 32953933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the Expression of
    Chen C; Chen S; Pang L; Yan H; Luo M; Zhao Q; Lai J; Li H
    Biomed Res Int; 2020; 2020():6412593. PubMed ID: 32104702
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Zhou Q; Zhang F; He Z; Zuo MZ
    Front Oncol; 2019; 9():161. PubMed ID: 30967995
    [No Abstract]   [Full Text] [Related]  

  • 5. CD96 as a Potential Diagnostic Biomarker and  New  Target for Skin Cutaneous Melanoma.
    Zhou W; Cai X; Liu F
    Contrast Media Mol Imaging; 2022; 2022():6409376. PubMed ID: 36043142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional E2F1/2/5/8 as potential targets and transcriptional E2F3/6/7 as new biomarkers for the prognosis of human lung carcinoma.
    Sun CC; Zhou Q; Hu W; Li SJ; Zhang F; Chen ZL; Li G; Bi ZY; Bi YY; Gong FY; Bo T; Yuan ZP; Hu WD; Zhan BT; Zhang Q; Tang QZ; Li DJ
    Aging (Albany NY); 2018 May; 10(5):973-987. PubMed ID: 29754146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Analysis of E2F Family Members in Human Gastric Cancer.
    Li S; Yang X; Li W; Chen Z
    Front Oncol; 2021; 11():625257. PubMed ID: 34532281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analysis of Prognostic and Immune Infiltrates for E2F Transcription Factors in Human Pancreatic Adenocarcinoma.
    Liu XS; Gao Y; Liu C; Chen XQ; Zhou LM; Yang JW; Kui XY; Pei ZJ
    Front Oncol; 2020; 10():606735. PubMed ID: 33604289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic values of
    Manicum T; Ni F; Ye Y; Fan X; Chen BC
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30487158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F1/2/7/8 as independent indicators of survival in patients with cervical squamous cell carcinoma.
    Yang C; Zhang ZC; Liu TB; Xu Y; Xia BR; Lou G
    Cancer Cell Int; 2020; 20():500. PubMed ID: 33061852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The E2F family as potential biomarkers and therapeutic targets in colon cancer.
    Yao H; Lu F; Shao Y
    PeerJ; 2020; 8():e8562. PubMed ID: 32117628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics Identification of the Expression and Clinical Significance of E2F Family in Endometrial Cancer.
    Zhang Y; Wang Z; Ma J; Huo J; Li Y; Wang Y; Chen H; Shan L; Ma X
    Front Genet; 2020; 11():557188. PubMed ID: 33329696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Values of E2F1/2 Transcriptional Expressions in Chromophobe Renal Cell Carcinoma Patients: Evidence from Bioinformatics Analysis.
    Hu D; Meng N; Lou X; Li Z; Teng Y; Tu B; Zou Y; Wang F
    Int J Gen Med; 2021; 14():3593-3609. PubMed ID: 34295182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and prognostic value of E2F activators in NSCLC and subtypes: a research based on bioinformatics analysis.
    Gao Z; Shi R; Yuan K; Wang Y
    Tumour Biol; 2016 Nov; 37(11):14979-14987. PubMed ID: 27655285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Analysis of E2F Expression and Its Relation in Colorectal Cancer Prognosis.
    Xu Z; Qu H; Ren Y; Gong Z; Ri HJ; Zhang F; Shao S; Chen X; Chen X
    Int J Gen Med; 2022; 15():4849-4870. PubMed ID: 35585998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of the functional and prognostic value of E2F transcription factors in human prostate cancer through data mining and experimental validation.
    Wang D; Tang W; Zhang P; Liu Z; Lyu F; Xiao Y; Ni D; Zhang P
    Transl Cancer Res; 2021 Dec; 10(12):5095-5109. PubMed ID: 35116361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression patterns of E2F transcription factors and their potential prognostic roles in breast cancer.
    Li Y; Huang J; Yang D; Xiang S; Sun J; Li H; Ren G
    Oncol Lett; 2018 Jun; 15(6):9216-9230. PubMed ID: 29844824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F1/2/4 mRNA is associated with immune infiltration and are potential biomarkers for the prognosis of human gastric carcinoma.
    Chen Y; Gong W; Dai W; Jiang H; Xu X
    Transl Cancer Res; 2021 Jun; 10(6):2801-2811. PubMed ID: 35116590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma.
    Huang YL; Ning G; Chen LB; Lian YF; Gu YR; Wang JL; Chen DM; Wei H; Huang YH
    Cancer Manag Res; 2019; 11():1725-1740. PubMed ID: 30863181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer.
    Han Z; Mo R; Cai S; Feng Y; Tang Z; Ye J; Liu R; Cai Z; Zhu X; Deng Y; Zou Z; Wu Y; Cai Z; Liang Y; Zhong W
    Front Cell Dev Biol; 2022; 10():831329. PubMed ID: 35531101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.